Keyphrases
Prostate Radiotherapy
100%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
100%
Precision Oncology
100%
Therapy Management
100%
Treatment Options
44%
Patient Selection
44%
Inhibitor-1
44%
Polyadenosine
44%
Polymerase Inhibitors
44%
PD-1 Inhibitor
44%
Novel Agents
33%
Targeted Therapy
22%
Sequential Use
22%
Predictive Biomarker
22%
Radium-223
22%
Translational Research
11%
Docetaxel
11%
Clinical Trials
11%
Androgen Receptor
11%
Phase II Trial
11%
Clinical Research
11%
Clinical Investigation
11%
Drug Development
11%
Sipuleucel-T
11%
Chemotherapy
11%
New Drugs
11%
Systemic Therapy
11%
Enzalutamide
11%
Immunotherapeutics
11%
Therapy Development
11%
Clinical Management
11%
Selection Strategy
11%
Denosumab
11%
Abiraterone
11%
Targeted Treatment
11%
International Meeting
11%
Advanced Prostate Cancer
11%
Bone Metastasis
11%
Castration-resistant
11%
Targeted Agents
11%
New Therapeutics
11%
Recent Advances
11%
Cabazitaxel
11%
Castration-sensitive
11%
Oncogenic Pathways
11%
Mismatch Repair
11%
Early Use
11%
Improved Survival
11%
MEDLINE
11%
Current Therapies
11%
Cochrane Library
11%
Systemic Treatment
11%
Good Strategies
11%
Active Agent
11%
PubMed
11%
Survival Benefit
11%
Evidence Acquisition
11%
Current Contents
11%
Web of Science
11%
Cumulative Survival Rate
11%
Sequence Method
11%
Sequential Development
11%
Treatment Selection
11%
Ongoing Development
11%
Homology-directed Repair
11%
Treatment Sequence
11%
Resistance Pattern
11%
Optimal Sequence
11%
Genetic Pathways
11%
Hormonal Therapy
11%
Support Measures
11%
Cancer Information
11%
Systemic Agents
11%
Existing Drugs
11%
Radionuclide Therapy
11%
Androgen Receptor Splice Variant 7
11%
WHO ICTRP
11%
Survival Improvement
11%
Resistance Development
11%
Immunotherapy Therapy
11%
Bone-modifying Agent
11%
Medicine and Dentistry
Oncology
100%
Prostate Cancer
100%
Cancer Therapy
100%
Castration Resistant Prostate Cancer
100%
Adenosine
44%
Polymerase
44%
Biological Marker
33%
Patient Selection
33%
Androgen Receptor
22%
Targeted Therapy
22%
Systemic Therapy
22%
Disease
11%
Chemotherapy
11%
Clinical Trial
11%
Clinical Research
11%
Translational Research
11%
Clinical Management
11%
Sipuleucel T
11%
Bone Metastasis
11%
Hormone Therapy
11%
Medicine
11%
DNA Mismatch Repair
11%
Radionuclide Therapy
11%
Abiraterone
11%
Immunotherapy
11%
Docetaxel
11%
Denosumab
11%
Enzalutamide
11%
Cabazitaxel
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Castration Resistant Prostate Cancer
100%
Adenosine
44%
Biological Marker
33%
Androgen Receptor
22%
Clinical Trial
11%
Drug Development
11%
Chemotherapy
11%
Enzalutamide
11%
Systemic Treatment
11%
Radioisotope
11%
Hormone Cancer Therapy
11%
Docetaxel
11%
Sipuleucel T
11%
Abiraterone
11%
Bone Metastasis
11%
Cabazitaxel
11%
Disease
11%
Immunotherapy
11%
Denosumab
11%